{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T13:32:55Z","timestamp":1791034375392,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"am","delay-in-days":349,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","amjmedsci.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.amjms.2024.07.028","type":"journal-article","created":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T15:43:50Z","timestamp":1722095030000},"page":"455-461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Patterns of gastroenterology specialty referral for primary care patients with metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1016","volume":"368","author":[{"given":"John F.G.","family":"Bobo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad A.","family":"Keith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Marsden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Schreiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.amjms.2024.07.028_bib0001","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41575-021-00477-7","article-title":"Defining comprehensive models of care for NAFLD","volume":"18","author":"Lazarus","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.amjms.2024.07.028_bib0002","article-title":"Advancing the global public health agenda for NAFLD: a consensus statement","author":"Lazarus","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.amjms.2024.07.028_bib0003","doi-asserted-by":"crossref","DOI":"10.2337\/dci21-0020","article-title":"Preparing for the NASH epidemic: a call to action","author":"Kanwal","year":"2021","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.amjms.2024.07.028_bib0004","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.amjms.2024.07.028_bib0005","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11606-022-07707-x","article-title":"Revisiting the time needed to provide adult primary care","volume":"38","author":"Porter","year":"2023","journal-title":"J Gen Intern Med"},{"issue":"6","key":"10.1016\/j.amjms.2024.07.028_bib0006","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1001\/jama.2014.7878","article-title":"Patient referrals: a linchpin for increasing the value of care","volume":"312","author":"Song","year":"2014","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.amjms.2024.07.028_bib0007","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1053\/j.gastro.2021.07.049","article-title":"Clinical Care pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease","volume":"161","author":"Kanwal","year":"2021","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.amjms.2024.07.028_bib0008","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"6","key":"10.1016\/j.amjms.2024.07.028_bib0009","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jhep.2017.07.027","article-title":"Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD","volume":"67","author":"Hagstrom","year":"2017","journal-title":"J Hepatol"},{"issue":"17","key":"10.1016\/j.amjms.2024.07.028_bib0010","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective study of outcomes in adults with nonalcoholic fatty liver disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.amjms.2024.07.028_bib0011","doi-asserted-by":"crossref","first-page":"e1612","DOI":"10.1053\/j.gastro.2020.01.043","article-title":"Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"158","author":"Taylor","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.amjms.2024.07.028_bib0012","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest","volume":"46","author":"Vallet-Pichard","year":"2007","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.amjms.2024.07.028_bib0013","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3452","article-title":"Advanced liver fibrosis and the metabolic syndrome in a primary care setting","author":"Schreiner","year":"2021","journal-title":"Diabetes Metab Res Rev"},{"issue":"10","key":"10.1016\/j.amjms.2024.07.028_bib0014","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/hep4.1411","article-title":"Impact of Implementing a \u201cFIB-4 First\u201d Strategy on a Pathway for Patients With NAFLD Referred From Primary Care","volume":"3","author":"Davyduke","year":"2019","journal-title":"Hepatol Commun"},{"issue":"2","key":"10.1016\/j.amjms.2024.07.028_bib0015","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s10620-022-07706-2","article-title":"Primary care providers and nonalcoholic fatty liver disease: a needs assessment survey","volume":"68","author":"Islam","year":"2023","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.amjms.2024.07.028_bib0016","article-title":"Nonalcoholic fatty liver disease underdiagnosis in primary care: what are we missing?","author":"Nielsen","year":"2021","journal-title":"J Gen Intern Med"},{"issue":"1","key":"10.1016\/j.amjms.2024.07.028_bib0017","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"10","key":"10.1016\/j.amjms.2024.07.028_bib0018","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.cgh.2018.01.042","article-title":"Positive predictive value of international classification of diseases, 10th revision, codes for cirrhosis and its related complications","volume":"16","author":"Mapakshi","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.amjms.2024.07.028_bib0019","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1097\/MCG.0b013e3182688d2f","article-title":"Use of administrative claims data for identifying patients with cirrhosis","volume":"47","author":"Nehra","year":"2013","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.amjms.2024.07.028_bib0020","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/hep.31726","article-title":"Administrative coding in electronic health care record-based research of NAFLD: an expert panel consensus statement","volume":"74","author":"Hagstr\u00f6m","year":"2021","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"4","key":"10.1016\/j.amjms.2024.07.028_bib0021","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/j.1475-6773.2007.00822.x","article-title":"Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database","volume":"43","author":"Quan","year":"2008","journal-title":"Health Serv Res"},{"issue":"11","key":"10.1016\/j.amjms.2024.07.028_bib0022","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"issue":"2","key":"10.1016\/j.amjms.2024.07.028_bib0023","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jhep.2019.03.033","article-title":"Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease","volume":"71","author":"Srivastava","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.amjms.2024.07.028_bib0024","article-title":"Easl clinical practice guidelines (Cpgs) on non-invasive tests for evaluation of liver disease severity and prognosis- 2020 update","author":"L","year":"2021","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.amjms.2024.07.028_bib0025","doi-asserted-by":"crossref","first-page":"e314","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.amjms.2024.07.028_bib0026","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.14309\/ajg.0000000000002098","article-title":"Exercise training is associated with treatment response in liver fat content by magnetic resonance imaging independent of clinically significant body weight loss in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"118","author":"Stine","year":"2023","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.amjms.2024.07.028_bib0027","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.amjms.2024.07.028_bib0028","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1468-0009.2011.00619.x","article-title":"Dropping the baton: specialty referrals in the United States","volume":"89","author":"Mehrotra","year":"2011","journal-title":"Milbank Q"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962924013855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962924013855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T16:32:08Z","timestamp":1729096328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962924013855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0002962924013855"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2024.07.028","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of gastroenterology specialty referral for primary care patients with metabolic dysfunction-associated steatotic liver disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2024.07.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}